Feb. 7, 2020 15:24 UTC Oragenics, Inc. to Present at the 22 nd Annual BIO CEO & Investor Conference TAMPA, Fla.--( BUSINESS WIRE )-- Oragenics, Inc. (NYSE American: OGEN) , a leader in the development of effective treatments for oral mucositis and new antibiotics against infectious diseases, announced today that Alan Joslyn, Ph.D., president and CEO of Oragenics, Inc., will present a corporate overview at the 22 nd Annual BIO CEO & Investor Conference being held on Feb
February 7, 2020
· 2 min read